Goldstein David
Chief Scientific Officer at ALMS; Chief Scientific Officer at Principia Biopharma Inc.
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 3, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALMSALUMIS INC.Chief Scientific Officer
- Principia Biopharma Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Principia Biopharma Inc.28,000 shares
- ALMS2,596 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Principia Biopharma Inc.UnusualNov 7 2019
Sold 10,000 shares at $32.39 ($324k)
Goldstein David, Chief Scientific Officer
Sold 25.1% of holdings ($1.3M position)29,819 shares leftFirst sale on recordFiling
- 2 Form 4 sale Principia Biopharma Inc.Plan not statedFeb 10 +95 days
Sold 6,000 shares at $70.90 ($425k)
Goldstein David, Chief Scientific Officer
Sold 16.2% of holdings ($2.6M position)30,968 shares leftFiling
- 3 Form 4 sale Principia Biopharma Inc.Plan not statedMay 7 +87 days
Sold 6,000 shares at $60.15 ($361k)
Goldstein David M, Chief Scientific Officer
Sold 16.2% of holdings ($2.2M position)30,968 shares leftFiling
- 4 Form 4 sale Principia Biopharma Inc.Plan not statedAug 10 +95 days
Sold 6,000 shares at $88.61 ($532k)
Goldstein David M, Chief Scientific Officer
Sold 15.9% of holdings ($3.3M position)31,739 shares left1x usual sizeFiling
- 5 Form 4 sale ALMSNo planAug 3 +2184 days
Sold 2,596 shares at $26.37 ($68k)
Goldstein David M, Chief Scientific Officer
No 10b5-1 planSold 7.7% of holdings ($885k position)30,970 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | ALMS | Chief Scientific Officer | Form 4 sale | 2,596 | $68k | 7.7% | No plan | SEC |
| Aug 10, 2020 | Principia Biopharma Inc. | Chief Scientific Officer | Form 4 sale | 6,000 | $532k | 15.9% | Plan not stated | SEC |
| May 7, 2020 | Principia Biopharma Inc. | Chief Scientific Officer | Form 4 sale | 6,000 | $361k | 16.2% | Plan not stated | SEC |
| Feb 10, 2020 | Principia Biopharma Inc. | Chief Scientific Officer | Form 4 sale | 6,000 | $425k | 16.2% | Plan not stated | SEC |
| Nov 7, 2019 | Principia Biopharma Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $324k | 25.1% | Unusual | SEC |